Ronald Allen Louks serves as Executive at NantHealth, Inc., where they oversee executive responsibilities. Since joining the company, Ronald Allen Louks has executed 58 insider transactions totaling $727.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 6, 2017 involved exercising options for 10,000 shares valued at $0.
Ronald Allen Louks currently holds 225,857 shares of NantHealth, Inc. (NH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Allen Louks has been a net seller of NH stock. They have purchased $0 and sold $727.9K worth of shares.
Ronald Allen Louks's most recent insider trade was on Nov 6, 2017, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.39 |
| Discretionary |
| Nov 6, 2017 | NH | $154.3K | Payment | 45,506 | $3.39 | Discretionary |
| Nov 6, 2017 | NH | $0 | Option Exercise | 125,196 | $N/A | Discretionary |
| Nov 6, 2017 | NH | $11.2K | Payment | 3,295 | $3.39 | Discretionary |
| Oct 6, 2017 | NH | $114.8K | Sale | 26,820 | $4.28 | Discretionary |
| Oct 6, 2017 | NH | $56.4K | Payment | 13,180 | $4.28 | Discretionary |
| Oct 6, 2017 | NH | $0 | Option Exercise | 40,000 | $N/A | Discretionary |